Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Botai Pharmaceutical Technology
Tianjin, Tianjin, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Tianjin Botai Pharmaceutical Technology Development Co., Ltd. (officially registered in English as Tianjin Langrui Pharmaceutical Technology Development Co., Ltd.) is a private Chinese pharmaceutical technology company founded in November 2017 and based in Tianjin. The company primarily focuses on providing technical development, technical consulting, technical transfer, and technical services within the field of pharmaceutical technology products. It operates as a service-oriented enterprise under the leadership of executive director Wang Yingshi.
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on Tianjin Botai Pharmaceutical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tianjin Botai Pharmaceutical Technology.